4D Molecular Therapeutics, Inc. - Common Stock, $0.0001 par value per share (FDMT)

CUSIP: 35104E100

Q4 2023 13F Holders as of 31 Dec 2023

Holder snapshot 7 signals
Share change
+520,093
Put/Call ratio
272%
SEC-reported price per share
$20.26
Number of holders
111
Value change
+$24,792,782
Number of buys
61
Open additional details 1 more signal available
Number of sells
47
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
51,571,939

Security key

35104E100

Report period

Q4 2023

Institutions

111

Top holders

10

Ownership snapshot

Top reported holders of FDMT - 4D Molecular Therapeutics, Inc. - Common Stock, $0.0001 par value per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
VIKING GLOBAL INVESTORS LP
Disclosed value leader
VIKING GLOBAL INVESTORS LP
Comparable rows
0/15
Latest evidence
30 Sep 2023
13F 3/4/5 Highest disclosed value: $60,950,145 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

VIKING GLOBAL INVESTORS LP has the largest disclosed position value at $60.95M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens VIKING GLOBAL INVESTORS LP's linked filing trail.
Disclosed position value Top 5
VIKING GLOBAL INVESTORS LP $60.95M
RA CAPITAL MANAGEMENT, L.P. $53M
BVF INC/IL $51.01M
BlackRock Finance, Inc. $39.76M
Venrock Adviser, LLC $38.19M

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
VIKING GLOBAL INVESTORS LP
13F
Company
13F
—
denominator unverified
$60,950,145
4,787,914 shares
— 30 Sep 2023
RA CAPITAL MANAGEMENT, L.P.
13F
Company
13F
—
denominator unverified
$52,997,676
4,163,211 shares
— 30 Sep 2023
BVF INC/IL
13F
Company
13F
—
denominator unverified
$51,014,367
4,007,413 shares
— 30 Sep 2023
BlackRock Finance, Inc.
13F
Company
13F
—
denominator unverified
$39,764,397
3,123,676 shares
— 30 Sep 2023
Venrock Adviser, LLC
13F
Company
13F
—
denominator unverified
$38,190,000
3,000,000 shares
— 30 Sep 2023
Deep Track Capital, LP
13F
Company
13F
—
denominator unverified
$35,365,302
2,778,107 shares
— 30 Sep 2023
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q4 2023

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
111
Shares
42,433,937
Rows available
111
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q4 2023 vs Q3 2023 Across Filers

Q3 2023 holders
110
Q4 2023 holders
111
Holder diff
1
Investor Q3 2023 Shares Q4 2023 Shares Share Diff Share Chg % Q3 2023 value Q4 2023 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .